{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:19:03Z","timestamp":1761844743485,"version":"3.41.0"},"publisher-location":"Cham","reference-count":151,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319559469"},{"type":"electronic","value":"9783319559476"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-55947-6_1","type":"book-chapter","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T10:53:51Z","timestamp":1496141631000},"page":"1-41","source":"Crossref","is-referenced-by-count":21,"title":["Circulating Tumor Cells as Cancer Biomarkers in the Clinic"],"prefix":"10.1007","author":[{"given":"Ludmilla Thom\u00e9 Domingos","family":"Chinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emne Ali","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexcia Camila","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca de C\u00e1ssia Troncarelli de Cam","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Corassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange Moraes","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello Ferretti","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"issue":"6","key":"1_CR1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/ijc.29495","volume":"137","author":"EA Abdallah","year":"2015","unstructured":"Abdallah EA, Fanelli MF, Buim ME et al (2015) Thymidylate synthase expression in circulating tumor cells: a new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients. Int J Cancer 137(6):1397\u20131405","journal-title":"Int J Cancer"},{"issue":"4","key":"1_CR2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ijc.30082","volume":"139","author":"EA Abdallah","year":"2016","unstructured":"Abdallah EA, Fanelli MF, Souza E, Silva V et al (2016) MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer. Int J Cancer 139(4):890\u2013898","journal-title":"Int J Cancer"},{"issue":"5","key":"1_CR3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","volume":"21","author":"B Aktas","year":"2011","unstructured":"Aktas B, Kasimir-Bauer S, Heubner M et al (2011) Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy. Int J Gynecol Cancer 21(5):822\u2013830","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1_CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/bjs.5526","volume":"94","author":"TG Allen-Mersh","year":"2007","unstructured":"Allen-Mersh TG, McCullough TK, Patel H et al (2007) Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg 94(1):96\u2013105","journal-title":"Br J Surg"},{"issue":"11","key":"1_CR5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","volume":"371","author":"ES Antonarakis","year":"2014","unstructured":"Antonarakis ES, Lu C, Wang H, Luber B et al (2014) AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 371(11):1028\u20131038","journal-title":"N Engl J Med"},{"key":"1_CR6","first-page":"146","volume":"14","author":"TR Ashworth","year":"1869","unstructured":"Ashworth TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Med J Aust 14:146\u2013147","journal-title":"Med J Aust"},{"issue":"6","key":"1_CR7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.breast.2013.08.014","volume":"22","author":"HA Azim Jr","year":"2013","unstructured":"Azim HA Jr, Roth\u00e9 F, Aura CM et al (2013) Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial. Breast 22(6):1060\u20131065","journal-title":"Breast"},{"issue":"1","key":"1_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.06.022","volume":"123","author":"K Behbakht","year":"2011","unstructured":"Behbakht K, Sill MW, Darcy KM et al (2011) Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 123(1):19\u201326","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1_CR9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1470-2045(16)00011-5","volume":"17","author":"F Bertucci","year":"2016","unstructured":"Bertucci F, Fekih M, Autret A et al (2016) Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study. Lancet Oncol 17(5):600\u2013611","journal-title":"Lancet Oncol"},{"issue":"4","key":"1_CR10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/annonc\/mdp391","volume":"21","author":"FC Bidard","year":"2010","unstructured":"Bidard FC, Mathiot C, Delaloge S et al (2010) Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol 21(4):729\u2013733","journal-title":"Ann Oncol"},{"issue":"8","key":"1_CR11","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/annonc\/mdt176","volume":"24","author":"FC Bidard","year":"2013","unstructured":"Bidard FC, Huguet F, Louvet C et al (2013) Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol 24(8):2057\u20132061","journal-title":"Ann Oncol"},{"issue":"4","key":"1_CR12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1470-2045(14)70069-5","volume":"15","author":"FC Bidard","year":"2014","unstructured":"Bidard FC, Peeters DJ, Fehm T et al (2014) Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 15(4):406\u2013414","journal-title":"Lancet Oncol"},{"issue":"20","key":"1_CR13","first-page":"4556","volume":"56","author":"B Brandt","year":"1996","unstructured":"Brandt B, Junker R, Griwatz C et al (1996) Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res 56(20):4556\u20134561","journal-title":"Cancer Res"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa050434","volume":"353","author":"S Braun","year":"2005","unstructured":"Braun S, Vogl FD, Naume B et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353:793\u2013802","journal-title":"N Engl J Med"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"41677","DOI":"10.18632\/oncotarget.9528","volume":"7","author":"M Bredemeier","year":"2016","unstructured":"Bredemeier M, Edimiris P, Tewes M et al (2016) Establishmernt of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment. Oncotarget 7:41677\u201341690","journal-title":"Oncotarget"},{"issue":"9","key":"1_CR16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/15384047.2015.1070991","volume":"16","author":"ME Buim","year":"2015","unstructured":"Buim ME, Fanelli MF, Souza VS et al (2015) Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer. Cancer Biol Ther 16(9):1289\u20131295","journal-title":"Cancer Biol Ther"},{"issue":"2\u20133","key":"1_CR17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10555-014-9502-8","volume":"33","author":"NJ Caixeiro","year":"2014","unstructured":"Caixeiro NJ, Kienzle N, Lim SH et al (2014) Circulating tumour cells\u2014a bona fide cause of metastatic cancer. Cancer Metastasis Rev 33(2\u20133):747\u2013756","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"1_CR18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1158\/0008-5472.CAN-14-2613","volume":"75","author":"L Cayrefourcq","year":"2015","unstructured":"Cayrefourcq L, Mazard T, Joosse S et al (2015) Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res 75(5):892\u2013901","journal-title":"Cancer Res"},{"issue":"8","key":"1_CR19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/pros.22625","volume":"73","author":"CL Chen","year":"2013","unstructured":"Chen CL, Mahalingam D, Osmulski P et al (2013) Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate 73(8):813\u2013826","journal-title":"Prostate"},{"issue":"8","key":"1_CR20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/JTO.0000000000000606","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen X, Zhou F, Li X et al (2015) Folate receptor-positive circulating tumor cell detected by LT-PCR-based method as a diagnostic biomarker for non-small-cell lung cancer. J Thorac Oncol 10(8):1163\u20131171","journal-title":"J Thorac Oncol"},{"issue":"5","key":"1_CR21","first-page":"593","volume":"5","author":"LT Chinen","year":"2013","unstructured":"Chinen LT, de Carvalho FM, Rocha BM et al (2013) Cytokeratin-based CTC counting unrelated to clinical follow-up. J Thorac Dis 5(5):593\u2013599","journal-title":"J Thorac Dis"},{"key":"1_CR22","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2147\/OTT.S62349","volume":"7","author":"LT Chinen","year":"2014","unstructured":"Chinen LT, Mello CA, Abdallah EA et al (2014) Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion. Onco Targets Ther 7:1609\u20131617","journal-title":"Onco Targets Ther"},{"doi-asserted-by":"crossref","unstructured":"Corassa M, Fanelli M, Guimar\u00e3es APG et al (2016) Circulating Tumor Cells (CTCs) as a new and additional approach to follow-up patients with serous papillary low-grade ovarian adenocarcinoma \u2013 a case report and review of the literature (submitted)","key":"1_CR23","DOI":"10.1186\/s41241-017-0030-z"},{"issue":"4","key":"1_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1470-2045(14)70091-9","volume":"15","author":"M Cristofanilli","year":"2014","unstructured":"Cristofanilli M (2014) Circulating tumour cells: telling the truth about metastasis. Lancet Oncol 15(4):365\u2013366","journal-title":"Lancet Oncol"},{"issue":"8","key":"1_CR25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Mathew JE et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781\u2013791","journal-title":"N Engl J Med"},{"issue":"5","key":"1_CR26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0026-895X(24)23190-4","volume":"55","author":"Y Cui","year":"1999","unstructured":"Cui Y, K\u00f6nig J, Buchholz JK et al (1999) Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55(5):929\u2013937","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.lungcan.2012.04.005","volume":"77","author":"M Das","year":"2012","unstructured":"Das M, Riess JW, Frankel P et al (2012) ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy. Lung Cancer 77(2):421\u2013426","journal-title":"Lung Cancer"},{"issue":"19","key":"1_CR28","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","volume":"14","author":"JS Bono de","year":"2008","unstructured":"de Bono JS, Scher HI, Montgomery RB et al (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14(19):6302\u20136309","journal-title":"Clin Cancer Res"},{"issue":"21","key":"1_CR29","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","volume":"364","author":"JS Bono de","year":"2011","unstructured":"de Bono JS, Logothetis CJ, Molina A et al (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. N Engl J Med 364(21):1995\u20132005","journal-title":"N Engl J Med"},{"issue":"1","key":"1_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/annonc\/mdp262","volume":"21","author":"U Giorgi De","year":"2010","unstructured":"De Giorgi U, Valeo V, Rohren E et al (2010) Circulating tumor cells and bone metastases as detected by FDG-PET\/CT in patients with metastatic breast cancer. Ann Oncol 21(1):33\u201339","journal-title":"Ann Oncol"},{"unstructured":"De Oliveira TB, Nicolau UR, Braun AC et al (2016) Detection of drug resistance proteins in CTC from patients with locally advanced head and neck squamous cell carcinoma and their relation with survival. 7th ECHNO (European Congress on Head and Neck Oncol) abstract OP011","key":"1_CR31"},{"issue":"8","key":"1_CR32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ctrv.2011.04.006","volume":"37","author":"LA Devriese","year":"2011","unstructured":"Devriese LA, Voest EE, Beijnen JH et al (2011) Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials. Cancer Treat Rev 37(8):579\u2013589","journal-title":"Cancer Treat Rev"},{"issue":"47","key":"1_CR33","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","volume":"22","author":"L Doyle","year":"2003","unstructured":"Doyle L, Ross DD (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22(47):7340\u20137358","journal-title":"Oncogene"},{"issue":"1","key":"1_CR34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2013.02.015","volume":"335","author":"F Fabbri","year":"2013","unstructured":"Fabbri F, Carloni S, Zoli W et al (2013) Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett 335(1):225\u2013231","journal-title":"Cancer Lett"},{"issue":"5","key":"1_CR35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759\u2013767","journal-title":"Cell"},{"issue":"4","key":"1_CR36","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.5301\/jbm.5000166","volume":"30","author":"E Fina","year":"2015","unstructured":"Fina E, Reduzzi C, Motta R et al (2015) Did circulating tumor cells tell us all they could? The missed circulating tumor cell message in breast cancer. Int J Biol Markers 30(4):e429\u2013e433","journal-title":"Int J Biol Markers"},{"issue":"4","key":"1_CR37","first-page":"1237","volume":"148","author":"MJ Flens","year":"1996","unstructured":"Flens MJ, Zaman GJ, van der Valk P et al (1996) Tissue distribution of the multidrug resistance protein. Am J Pathol 148(4):1237\u20131247","journal-title":"Am J Pathol"},{"issue":"34","key":"1_CR38","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1200\/JCO.2011.39.0187","volume":"29","author":"E Fonkem","year":"2011","unstructured":"Fonkem E, Lun M, Wong ET (2011) Rare phenomenon of extracranial metastasis of glioblastoma. J Clin Oncol 29(34):4594\u20134595","journal-title":"J Clin Oncol"},{"issue":"5","key":"1_CR39","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/bcr3333","volume":"14","author":"B Franken","year":"2012","unstructured":"Franken B, de Groot MR, Mastboom WJ et al (2012) Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer. Breast Cancer Res 14(5):R133","journal-title":"Breast Cancer Res"},{"key":"1_CR40","doi-asserted-by":"crossref","first-page":"71330","DOI":"10.18632\/oncotarget.11114","volume":"7","author":"F Gao","year":"2016","unstructured":"Gao F, Cui Y, Jiang H et al (2016) Circulating tumor cell is a common property of brain glioma and promotes the monitoring system. Oncotarget 7:71330\u201371340","journal-title":"Oncotarget"},{"key":"1_CR41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fonc.2012.00128","volume":"2","author":"A Garcia-Villa","year":"2012","unstructured":"Garcia-Villa A, Balasubramanian P, Miller BL et al (2012) Assessment of \u03b3-H2AX levels in circulating tumor cells from patients receiving chemotherapy. Front Oncol 2:128","journal-title":"Front Oncol"},{"issue":"1","key":"1_CR42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1373\/clinchem.2012.188557","volume":"59","author":"C Gasch","year":"2013","unstructured":"Gasch C, Bauernhofer T, Pichler M et al (2013) Heterogeneity of epidermal growth factor receptor status and mutations of KRAS\/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin Chem 59(1):252\u2013260","journal-title":"Clin Chem"},{"doi-asserted-by":"crossref","unstructured":"Gasch C, Oldopp T, Mauermann O et al (2016) Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer. Mol Oncol pii: S1574-7891(16)30065-5","key":"1_CR43","DOI":"10.1016\/j.molonc.2016.07.005"},{"issue":"10","key":"1_CR44","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/ijc.24953","volume":"126","author":"P Gazzaniga","year":"2010","unstructured":"Gazzaniga P, Naso G, Gradilone A et al (2010) Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors. Int J Cancer 126(10):2437\u20132447","journal-title":"Int J Cancer"},{"issue":"10","key":"1_CR45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883\u2013892","journal-title":"N Engl J Med"},{"issue":"11","key":"1_CR46","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2013.51.7417","volume":"32","author":"A Goldkorn","year":"2014","unstructured":"Goldkorn A, Ely B, Quinn DI et al (2014) Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. J Clin Oncol 32(11):1136\u20131142","journal-title":"J Clin Oncol"},{"issue":"1","key":"1_CR47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/annonc\/mdq323","volume":"22","author":"A Gradilone","year":"2010","unstructured":"Gradilone A, Naso G, Raimondi C et al (2010) Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Ann Oncol 22(1):86\u201392","journal-title":"Ann Oncol"},{"issue":"6","key":"1_CR48","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/COC.0b013e3181f94596","volume":"34","author":"A Gradilone","year":"2011","unstructured":"Gradilone A, Raimondi C, Naso G et al (2011a) How circulating tumor cells escape from multidrug resistance: translating molecular mechanisms in metastatic breast cancer treatment. Am J Clin Oncol 34(6):625\u2013627","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"1_CR49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/annonc\/mdq323","volume":"22","author":"A Gradilone","year":"2011","unstructured":"Gradilone A, Naso G, Raimondi C et al (2011b) Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Ann Oncol 22(1):86\u201392","journal-title":"Ann Oncol"},{"issue":"4","key":"1_CR50","first-page":"611","volume":"75","author":"J Gunn","year":"1996","unstructured":"Gunn J, McCall JL, Yun K et al (1996) Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Investig 75(4):611\u2013616","journal-title":"Lab Investig"},{"issue":"1","key":"1_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2011.03.026","volume":"145","author":"DA Haber","year":"2011","unstructured":"Haber DA, Gray NS, Baselga J (2011) The evolving war on cancer. Cell 145(1):19\u201324","journal-title":"Cell"},{"issue":"3","key":"1_CR52","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s13277-013-1327-5","volume":"35","author":"L Han","year":"2014","unstructured":"Han L, Chen W, Zhao Q (2014) Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. Tumour Biol 35(3):2473\u20132480","journal-title":"Tumour Biol"},{"issue":"2","key":"1_CR53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/joim.12047","volume":"274","author":"DF Hayes","year":"2013","unstructured":"Hayes DF, Paoletti C (2013) Circulating tumour cells: insights into tumour heterogeneity. J Intern Med 274(2):137\u2013143","journal-title":"J Intern Med"},{"key":"1_CR54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1186\/s12885-015-1989-z","volume":"15","author":"S Hinz","year":"2015","unstructured":"Hinz S, R\u00f6der C, Tepel J et al (2015) Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer. BMC Cancer 15:953","journal-title":"BMC Cancer"},{"key":"1_CR55","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00428-016-2004-z","volume":"469","author":"P Hofman","year":"2016","unstructured":"Hofman P, Popper HH (2016) Pathologists and liquid biopsies: to be or not to be? Virchows Arch 469:601\u2013609","journal-title":"Virchows Arch"},{"issue":"7","key":"1_CR56","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ijc.25819","volume":"129","author":"V Hofman","year":"2011","unstructured":"Hofman V, Ilie MI, Long E et al (2011) Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay\u2122 and the isolation by size of epithelial tumor cell method. Int J Cancer 129(7):1651\u20131660","journal-title":"Int J Cancer"},{"issue":"5","key":"1_CR57","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/jid.2012.485","volume":"133","author":"V Hofman","year":"2013","unstructured":"Hofman V, Ilie M, Long-Mira E et al (2013) Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients. J Invest Dermatol 133(5):1378\u20131381","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1_CR58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2174\/1566524014666140414205455","volume":"14","author":"V Hofman","year":"2014","unstructured":"Hofman V, Ilie M, Long E et al (2014) Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls. Curr Mol Med 14(4):440\u2013456","journal-title":"Curr Mol Med"},{"issue":"6","key":"1_CR59","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cncy.21651","volume":"124","author":"VJ Hofman","year":"2016","unstructured":"Hofman VJ, Ilie M, Hofman PM (2016) Detection and characterization of circulating tumor cells in lung cancer: why and how? Cancer Cytopathol 124(6):380\u2013387","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"1_CR60","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB et al (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13(10):714\u2013726","journal-title":"Nat Rev Cancer"},{"key":"1_CR61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.08.020","volume":"106","author":"W Hong","year":"2016","unstructured":"Hong W, Lee S, Chang HJ et al (2016) Multifunctional magnetic nanowires: a novel breakthrough for ultrasensitive detection and isolation of rare cancer cells from non-metastatic early breast cancer patients using small volumes of blood. Biomaterials 106:78\u201386","journal-title":"Biomaterials"},{"issue":"31","key":"1_CR62","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2011.40.0887","volume":"30","author":"S Hoshimoto","year":"2012","unstructured":"Hoshimoto S, Shingai T, Morton DL et al (2012a) Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. J Clin Oncol 30(31):3819\u20133826","journal-title":"J Clin Oncol"},{"issue":"2","key":"1_CR63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/SLA.0b013e3182380f56","volume":"255","author":"S Hoshimoto","year":"2012","unstructured":"Hoshimoto S, Faries MB, Morton DL et al (2012b) Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma. Ann Surg 255(2):357\u2013362","journal-title":"Ann Surg"},{"issue":"5","key":"1_CR64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","volume":"30","author":"JM Hou","year":"2012","unstructured":"Hou JM, Krebs MG, Lancashire L et al (2012) Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 30(5):525\u2013532","journal-title":"J Clin Oncol"},{"issue":"5416","key":"1_CR65","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1126\/science.284.5416.958","volume":"284","author":"AB Houtsmuller","year":"1999","unstructured":"Houtsmuller AB, Rademakers S, Nigg AL et al (1999) Action of DNA repair endonuclease ERCC1\/XPF in living cells. Science 284(5416):958\u2013961","journal-title":"Science"},{"issue":"4","key":"1_CR66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tranon.2016.06.006","volume":"9","author":"MY Huang","year":"2016","unstructured":"Huang MY, Tsai HL, Huang JJ et al (2016) Clinical implications and future perspectives of circulating tumor cells and biomarkers in clinical outcomes of colorectal cancer. Transl Oncol 9(4):340\u2013347","journal-title":"Transl Oncol"},{"issue":"11","key":"1_CR67","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3816\/CBC.2007.n.054","volume":"7","author":"M Ignatiadis","year":"2007","unstructured":"Ignatiadis M, Perraki M, Apostolaki S et al (2007) Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer. Clin Breast Cancer 7(11):883\u2013889","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"1_CR68","first-page":"297","volume":"28","author":"H Iinuma","year":"2006","unstructured":"Iinuma H, Okinaga K, Egami H et al (2006) Usefulness and clinical significance of quantitative real-time RTPCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol 28(2):297\u2013306","journal-title":"Int J Oncol"},{"issue":"11","key":"1_CR69","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/annonc\/mds137","volume":"23","author":"M Ilie","year":"2012","unstructured":"Ilie M, Long E, Butori C et al (2012) ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma. Ann Oncol 23(11):2907\u20132913","journal-title":"Ann Oncol"},{"issue":"10","key":"1_CR70","doi-asserted-by":"crossref","first-page":"e111597","DOI":"10.1371\/journal.pone.0111597","volume":"9","author":"M Ilie","year":"2014","unstructured":"Ilie M, Hofman V, Long-Mira E et al (2014) \u201cSentinel\u201d circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One 9(10):e111597","journal-title":"PLoS One"},{"issue":"9","key":"1_CR71","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1373\/clinchem.2010.143297","volume":"56","author":"Y Jiang","year":"2010","unstructured":"Jiang Y, Palma JF, Agus DB et al (2010) Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate\u00a0cancer. Clin Chem 56(9):1492\u20131495","journal-title":"Clin Chem"},{"issue":"8","key":"1_CR72","doi-asserted-by":"crossref","first-page":"e104902","DOI":"10.1371\/journal.pone.0104902","volume":"9","author":"A Kalikaki","year":"2014","unstructured":"Kalikaki A, Politaki H, Souglakos J et al (2014) KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer. PLoS One 9(8):e104902","journal-title":"PLoS One"},{"issue":"1","key":"1_CR73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-011-0731-1","volume":"107","author":"G Kalokhe","year":"2012","unstructured":"Kalokhe G, Grimm SA, Chandler JP et al (2012) Metastatic glioblastoma: case presentations and a review of the literature. J Neuro-Oncol 107(1):21\u201327","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"1_CR74","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccr.2013.04.017","volume":"23","author":"Y Kang","year":"2013","unstructured":"Kang Y, Pantel K (2013) Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 23(5):573\u2013581","journal-title":"Cancer Cell"},{"issue":"1","key":"1_CR75","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr3099","volume":"14","author":"S Kasimir-Bauer","year":"2012","unstructured":"Kasimir-Bauer S, Hoffmann O, Wallwiener D et al (2012) Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res 14(1):R15","journal-title":"Breast Cancer Res"},{"issue":"5","key":"1_CR76","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10147-006-0590-5","volume":"11","author":"K Katsumata","year":"2006","unstructured":"Katsumata K, Sumi T, Mori Y et al (2006) Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR. Int J Clin Oncol 11(5):385\u2013389","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"1_CR77","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","volume":"139","author":"MY Kim","year":"2009","unstructured":"Kim MY, Oskarsson T, Acharyya S et al (2009) Tumor self-seeding by circulating cancer cells. Cell 139(7):1315\u20131326","journal-title":"Cell"},{"issue":"9","key":"1_CR78","first-page":"1856","volume":"55","author":"EC Kohn","year":"1995","unstructured":"Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55(9):1856\u20131862","journal-title":"Cancer Res"},{"issue":"12","key":"1_CR79","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.2010.28.7045","volume":"29","author":"MG Krebs","year":"2011","unstructured":"Krebs MG, Sloane R, Priest L et al (2011) Evaluation and prognostic significance of circulating tumor cells in patients with non\u2013small-cell lung cancer. J Clin Oncol 29(12):1556\u20131563","journal-title":"J Clin Oncol"},{"issue":"10","key":"1_CR80","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nrclinonc.2013.158","volume":"10","author":"EA Kuczynski","year":"2013","unstructured":"Kuczynski EA, Sargent DJ, Grothey A et al (2013) Drug rechallenge and treatment beyond progression\u2014implications for drug resistance. Nat Rev Clin Oncol 10(10):571\u2013587","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"1_CR81","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","volume":"60","author":"JD Kuhlmann","year":"2014","unstructured":"Kuhlmann JD, Wimberger P, Bankfalvi A et al (2014) ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance. Clin Chem 60(10):1282\u20131289","journal-title":"Clin Chem"},{"issue":"2","key":"1_CR82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00534-007-1250-5","volume":"15","author":"T Kurihara","year":"2008","unstructured":"Kurihara T, Itoi T, Sofuni A et al (2008) Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepato-Biliary-Pancreat Surg 15(2):189\u2013195","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"issue":"12","key":"1_CR83","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1038\/bjc.2013.265","volume":"108","author":"ES Lianidou","year":"2013","unstructured":"Lianidou ES, Mavroudis D, Georgoulias V (2013) Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer. Br J Cancer 108(12):2426\u20132432","journal-title":"Br J Cancer"},{"issue":"3","key":"1_CR84","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/10408363.2014.896316","volume":"51","author":"ES Lianidou","year":"2014","unstructured":"Lianidou ES, Strati A, Markou A (2014) Circulating tumor cells as promising novel biomarkers in solid cancers. Crit Rev Clin Lab Sci 51(3):160\u2013171","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"12","key":"1_CR85","doi-asserted-by":"crossref","first-page":"e80458","DOI":"10.1371\/journal.pone.0080458","volume":"8","author":"J Lou","year":"2013","unstructured":"Lou J, Ben S, Yang G et al (2013) Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR. PLoS One 8(12):e80458","journal-title":"PLoS One"},{"issue":"2","key":"1_CR86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12094-012-0775-5","volume":"14","author":"LE Lowes","year":"2012","unstructured":"Lowes LE, Lock M, Rodrigues G et al (2012) Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy. Clin Transl Oncol 14(2):150\u2013156","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"1_CR87","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1470-2045(12)70209-7","volume":"13","author":"A Lucci","year":"2012","unstructured":"Lucci A, Hall CS, Lodhi AK et al (2012) Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13(7):688\u2013695","journal-title":"Lancet Oncol"},{"issue":"9","key":"1_CR88","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00384-014-1958-z","volume":"29","author":"E Magni","year":"2014","unstructured":"Magni E, Botteri E, Ravenda PS et al (2014) Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery. Int J Color Dis 29(9):1053\u20131059","journal-title":"Int J Color Dis"},{"issue":"4","key":"1_CR89","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMoa0800668","volume":"359","author":"S Maheswaran","year":"2008","unstructured":"Maheswaran S, Sequist LV, Nagrath S et al (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359(4):366\u2013377","journal-title":"N Engl J Med"},{"issue":"4","key":"1_CR90","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ et al (2008) The epithelial mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704\u2013715","journal-title":"Cell"},{"issue":"1","key":"1_CR91","first-page":"105","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 1805(1):105\u2013117","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"1_CR92","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.molonc.2015.05.009","volume":"9","author":"M Mazel","year":"2015","unstructured":"Mazel M, Jacot W, Pantel K (2015) Frequent expression of PD-L1 on circulating breast cancer cells. Mol Oncol 9(9):1773\u20131782","journal-title":"Mol Oncol"},{"issue":"12","key":"1_CR93","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrclinonc.2010.171","volume":"7","author":"M Mego","year":"2010","unstructured":"Mego M, Mani SA, Cristofanilli M (2010) Molecular mechanisms of metastasis in breast cancer-clinical applications. Nat Rev Clin Oncol 7(12):693\u2013701","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"1_CR94","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ijc.26037","volume":"130","author":"M Mego","year":"2012","unstructured":"Mego M, Mani SA, Lee B et al (2012) Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: the effect of neoadjuvant therapy. Int J Cancer 130(4):808\u2013816","journal-title":"Int J Cancer"},{"issue":"22","key":"1_CR95","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/1078-0432.CCR-14-3129","volume":"21","author":"N Mehra","year":"2015","unstructured":"Mehra N, Zafeiriou Z, Lorente D et al (2015) CCR 20th anniversary commentary: circulating tumor cells in prostate cancer. Clin Cancer Res 21(22):4992\u20134995","journal-title":"Clin Cancer Res"},{"issue":"24","key":"1_CR96","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1158\/1078-0432.CCR-04-1110","volume":"10","author":"S Meng","year":"2004","unstructured":"Meng S, Tripathy D, Frenkel EP et al (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 10(24):8152\u20138162","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1_CR97","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/2159-8290.CD-12-0222","volume":"2","author":"DT Miyamoto","year":"2012","unstructured":"Miyamoto DT, Lee RJ, Stott SL et al (2012) Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov 2(11):995\u20131003","journal-title":"Cancer Discov"},{"issue":"6254","key":"1_CR98","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.aab0917","volume":"349","author":"DT Miyamoto","year":"2015","unstructured":"Miyamoto DT, Zheng Y, Wittner BS et al (2015) RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 349(6254):1351\u20131356","journal-title":"Science"},{"issue":"8","key":"1_CR99","doi-asserted-by":"crossref","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","volume":"3","author":"AP Morel","year":"2008","unstructured":"Morel AP, Lievre M, Thomas C et al (2008) Generation of breast cancer stem cells through epithelial mesenchymal transition. PLoS One 3(8):e2888","journal-title":"PLoS One"},{"issue":"1","key":"1_CR100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijc.27987","volume":"133","author":"B Mostert","year":"2013","unstructured":"Mostert B, Jiang Y, Sieuwerts AM et al (2013) KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. Int J Cancer 133(1):130\u2013141","journal-title":"Int J Cancer"},{"issue":"1","key":"1_CR101","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/cancers6010153","volume":"6","author":"L Muinelo-Romay","year":"2014","unstructured":"Muinelo-Romay L, Vieito M, Abalo A et al (2014) Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment. Cancers (Basel) 6(1):153\u2013165","journal-title":"Cancers (Basel)"},{"issue":"247","key":"1_CR102","doi-asserted-by":"crossref","first-page":"247ra101","DOI":"10.1126\/scitranslmed.3009095","volume":"6","author":"C M\u00fcller","year":"2014","unstructured":"M\u00fcller C, Holtschmidt J, Auer M et al (2014) Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 6(247):247ra101","journal-title":"Sci Transl Med"},{"issue":"11","key":"1_CR103","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.7314\/APJCP.2015.16.11.4745","volume":"16","author":"NP Murray","year":"2015","unstructured":"Murray NP, Albarran V, Perez G et al (2015) Secondary Circulating Tumor Cells (CTCs) but not primary CTCs are associated with the clinico-pathological parameters in Chilean patients with Colo-rectal cancer. Asian Pac J Cancer Prev 16(11):4745\u20134749","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"1_CR104","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/ijc.28263","volume":"133","author":"R Nadal","year":"2013","unstructured":"Nadal R, Ortega FG, Salido M et al (2013) CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy. Int J Cancer 133(10):2398\u20132407","journal-title":"Int J Cancer"},{"key":"1_CR105","doi-asserted-by":"crossref","first-page":"712827","DOI":"10.1155\/2014\/712827","volume":"2014","author":"D Nesteruk","year":"2014","unstructured":"Nesteruk D, Rutkowski A, Fabisiewicz S et al (2014) Evaluation of prognostic significance of circulating tumor cells detection in rectal cancer patients treated with preoperative radiotherapy: prospectively collected material data. Biomed Res Int 2014:712827","journal-title":"Biomed Res Int"},{"issue":"5","key":"1_CR106","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/annonc\/mdm558","volume":"19","author":"F Nol\u00e9","year":"2008","unstructured":"Nol\u00e9 F, Munzone E, Zorzino L et al (2008) Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann Oncol 19(5):891\u2013897","journal-title":"Ann Oncol"},{"issue":"13","key":"1_CR107","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMc0801440","volume":"358","author":"S Paik","year":"2008","unstructured":"Paik S, Kim C, Wolmark N (2008) HER2 status and benefit from adjuvant trastuzumab in breast cancer. N Engl J Med 358(13):1409\u20131411","journal-title":"N Engl J Med"},{"issue":"18","key":"1_CR108","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1200\/JCO.2012.44.5932","volume":"31","author":"E Pailler","year":"2013","unstructured":"Pailler E, Adam J, Barth\u00e9l\u00e9my A et al (2013) Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer. J Clin Oncol 31(18):2273\u20132281","journal-title":"J Clin Oncol"},{"issue":"7","key":"1_CR109","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/annonc\/mdv165","volume":"26","author":"E Pailler","year":"2015","unstructured":"Pailler E, Auger N, Lindsay CR et al (2015) High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer. Ann Oncol 26(7):1408\u20131415","journal-title":"Ann Oncol"},{"issue":"5","key":"1_CR110","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1373\/clinchem.2011.175570","volume":"58","author":"K Pantel","year":"2012","unstructured":"Pantel K, Den\u00e8ve E, Nocca D et al (2012) Circulating epithelial cells in patients with benign colon diseases. Clin Chem 58(5):936\u2013940","journal-title":"Clin Chem"},{"issue":"11","key":"1_CR111","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1158\/1078-0432.CCR-14-1913","volume":"21","author":"C Paoletti","year":"2015","unstructured":"Paoletti C, Mu\u00f1iz MC, Thomas DG et al (2015) Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. Clin Cancer Res 21(11):2487\u20132498","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1_CR112","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12307-014-0164-4","volume":"7","author":"P Paterlini-Br\u00e9chot","year":"2014","unstructured":"Paterlini-Br\u00e9chot P (2014) Circulating tumor cells: who is the killer? Cancer Microenviron 7(3):161\u2013176","journal-title":"Cancer Microenviron"},{"issue":"2","key":"1_CR113","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2006.12.014","volume":"253","author":"P Paterlini-Brechot","year":"2007","unstructured":"Paterlini-Brechot P, Benali NL (2007) Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253(2):180\u2013204","journal-title":"Cancer Lett"},{"issue":"18","key":"1_CR114","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.286.18.2270","volume":"286","author":"KA Phillips","year":"2001","unstructured":"Phillips KA, Veenstra DL, Oren E (2001) Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 286(18):2270\u20132279","journal-title":"JAMA"},{"issue":"21","key":"1_CR115","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/1078-0432.CCR-08-0030","volume":"14","author":"JY Pierga","year":"2008","unstructured":"Pierga JY, Bidard FC, Mathiot C et al (2008) Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res 14(21):7004\u20137010","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1_CR116","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(12)70049-9","volume":"13","author":"JY Pierga","year":"2012","unstructured":"Pierga JY, Petit T, Delozier T et al (2012) Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study. Lancet Oncol 13(4):375\u2013384","journal-title":"Lancet Oncol"},{"issue":"6","key":"1_CR117","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.humpath.2006.01.026","volume":"37","author":"P Pinzani","year":"2006","unstructured":"Pinzani P, Salvadori B, Simi L et al (2006) Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum Pathol 37(6):711\u2013718","journal-title":"Hum Pathol"},{"issue":"3","key":"1_CR118","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1200\/JCO.2004.05.064","volume":"22","author":"S Popat","year":"2004","unstructured":"Popat S, Matakidou A, Houlston RS (2004) Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 22(3):529\u2013536","journal-title":"J Clin Oncol"},{"issue":"3","key":"1_CR119","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","volume":"122","author":"A Poveda","year":"2011","unstructured":"Poveda A, Kaye SB, McCormack R et al (2011) Circulating tumor cells predict PFS and overall survival in patients with relapsed\/recurrent advanced ovarian cancer. Gynecol Oncol 122(3):567\u2013572","journal-title":"Gynecol Oncol"},{"issue":"8","key":"1_CR120","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1078-0432.CCR-11-3148","volume":"18","author":"EA Punnoose","year":"2012","unstructured":"Punnoose EA, Atwal S, Liu W et al (2012) Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 18(8):2391\u20132401","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1_CR121","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/bjc.2015.332","volume":"113","author":"EA Punnoose","year":"2015","unstructured":"Punnoose EA, Ferraldeschi R, Szafer-Glusman E et al (2015) PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients. Br J Cancer 113(8):1225\u20131233","journal-title":"Br J Cancer"},{"doi-asserted-by":"crossref","unstructured":"Rack B, Schindlbeck C, J\u00fcckstock J et al (2014) Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. J Natl Cancer Inst 106(5):dju066","key":"1_CR122","DOI":"10.1093\/jnci\/dju066"},{"issue":"5","key":"1_CR123","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2010.01.008","volume":"138","author":"NN Rahbari","year":"2010","unstructured":"Rahbari NN, Aigner M, Thorlund K et al (2010) Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterol 138(5):1714\u20131726","journal-title":"Gastroenterol"},{"issue":"5","key":"1_CR124","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4161\/cbt.28020","volume":"15","author":"C Raimondi","year":"2014","unstructured":"Raimondi C, Nicolazzo C, Gradilone A et al (2014) Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer. Cancer Biol Ther 15(5):496\u2013503","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"1_CR125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000123852","volume":"75","author":"S Riethdorf","year":"2008","unstructured":"Riethdorf S, Pantel K (2008) Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology 75(2):140\u2013148","journal-title":"Pathobiology"},{"key":"1_CR126","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1749-6632.2010.05779.x","volume":"1210","author":"S Riethdorf","year":"2010","unstructured":"Riethdorf S, Pantel K (2010) Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells. Ann N Y Acad Sci 1210:66\u201377","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"1_CR127","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/1078-0432.CCR-09-2042","volume":"16","author":"S Riethdorf","year":"2010","unstructured":"Riethdorf S, M\u00fcller V, Zhang L et al (2010a) Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin Cancer Res 16(9):2634\u20132645","journal-title":"Clin Cancer Res"},{"issue":"24 Suppl","key":"1_CR128","first-page":"PD04-6-PD-6","volume":"70","author":"S Riethdorf","year":"2010","unstructured":"Riethdorf S, Mueller V, Mauermann O et al (2010b) Abstract PD04-06: changes in circulating tumor and endothelial cells in peripheral blood of patients treated in the neoadjuvant chemotherapy plus targeted treatment breast cancer study \u201cGeparQuinto\u201d. Cancer Res 70(24 Suppl):PD04-6-PD-6","journal-title":"Cancer Res"},{"issue":"1","key":"1_CR129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd705","volume":"1","author":"DM Roden","year":"2002","unstructured":"Roden DM, George AL Jr (2002) The genetic basis of variability in drug responses. Nat Rev Drug Discov 1(1):37\u201344","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1_CR130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737159.2016.1116942","volume":"16","author":"F Salvianti","year":"2016","unstructured":"Salvianti F, Pazzagli M, Pinzani P (2016) Single circulating tumor cell sequencing as an advanced tool in cancer management. Expert Rev Mol Diagn 16(1):51\u201363","journal-title":"Expert Rev Mol Diagn"},{"key":"1_CR131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0065-230X(06)96008-4","volume":"96","author":"D Sarker","year":"2007","unstructured":"Sarker D, Workman P (2007) Pharmacodynamic biomarkers for molecular cancer therapeutics. Adv Cancer Res 96:213\u2013268","journal-title":"Adv Cancer Res"},{"issue":"5","key":"1_CR132","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/annonc\/mdm583","volume":"19","author":"J Sastre","year":"2008","unstructured":"Sastre J, Maestro ML, Puente J et al (2008) Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 19(5):935\u2013938","journal-title":"Ann Oncol"},{"issue":"4","key":"1_CR133","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clcc.2013.06.001","volume":"12","author":"J Sastre","year":"2013","unstructured":"Sastre J, Vidaurreta M, G\u00f3mez A et al (2013) Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab. Clin Colorectal Cancer 12(4):280\u2013286","journal-title":"Clin Colorectal Cancer"},{"key":"1_CR134","doi-asserted-by":"crossref","first-page":"28910","DOI":"10.1038\/srep28910","volume":"6","author":"A Satelli","year":"2016","unstructured":"Satelli A, Batth IS, Brownlee Z et al (2016) Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients. Sci Rep 6:28910","journal-title":"Sci Rep"},{"issue":"3","key":"1_CR135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/cas.12868","volume":"107","author":"T Sawada","year":"2016","unstructured":"Sawada T, Watanabe M, Fujimura Y et al (2016) Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells. Cancer Sci 107(3):307\u2013314","journal-title":"Cancer Sci"},{"issue":"13","key":"1_CR136","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher HI, Fizazi K, Saad F et al (2012) Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 367(13):1187\u20131197","journal-title":"N Engl J Med"},{"issue":"12","key":"1_CR137","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2014.55.3487","volume":"33","author":"HI Scher","year":"2015","unstructured":"Scher HI, Heller G, Molina A et al (2015) Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. J Clin Oncol 33(12):1348\u20131355","journal-title":"J Clin Oncol"},{"key":"1_CR138","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/jamaoncol.2016.1828","volume":"2","author":"HI Scher","year":"2016","unstructured":"Scher HI, Lu D, Schreiber NA et al (2016) Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer. JAMA Oncol 2:1441\u20131449","journal-title":"JAMA Oncol"},{"issue":"3","key":"1_CR139","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.molonc.2013.02.013","volume":"7","author":"JB Smerage","year":"2013","unstructured":"Smerage JB, Budd GT, Doyle GV et al (2013) Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer. Mol Oncol 7(3):680\u2013692","journal-title":"Mol Oncol"},{"issue":"31","key":"1_CR140","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1200\/JCO.2014.56.2561","volume":"32","author":"JB Smerage","year":"2014","unstructured":"Smerage JB, Barlow WE, Hortobagyi GN et al (2014) Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J Clin Oncol 32(31):3483\u20133489","journal-title":"J Clin Oncol"},{"issue":"1","key":"1_CR141","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10549-011-1508-0","volume":"128","author":"G Somlo","year":"2011","unstructured":"Somlo G, Lau SK, Frankel P et al (2011) Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced\/inflammatory, and stage IV breast cancer, using a novel detection technology. Breast Cancer Res Treat 128(1):155\u2013163","journal-title":"Breast Cancer Res Treat"},{"key":"1_CR142","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3925","author":"J Steinestel","year":"2015","unstructured":"Steinestel J, Luedeke M, Arndt A et al (2015) Detecting predictive androgen receptor modifications in circulating prostate cancer cells. Oncotarget. doi: 10.18632\/oncotarget.3925","journal-title":"Oncotarget"},{"issue":"6","key":"1_CR143","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejso.2011.01.025","volume":"37","author":"M Thorsteinsson","year":"2011","unstructured":"Thorsteinsson M, Jess P (2011) The clinical significance of circulating tumor cells in non-metastatic colorectal cancer\u2014a review. Eur J Surg Oncol 37(6):459\u2013465","journal-title":"Eur J Surg Oncol"},{"key":"1_CR144","doi-asserted-by":"crossref","first-page":"24517","DOI":"10.1038\/srep24517","volume":"6","author":"WS Tsai","year":"2016","unstructured":"Tsai WS, Chen JS, Shao HJ et al (2016) Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients. Sci Rep 6:24517","journal-title":"Sci Rep"},{"issue":"8","key":"1_CR145","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1245\/s10434-008-9961-7","volume":"15","author":"YH Uen","year":"2008","unstructured":"Uen YH, Lu CY, Tsai HL et al (2008) Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol 15(8):2120\u20132128","journal-title":"Ann Surg Oncol"},{"key":"1_CR146","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.ejso.2016.05.010","volume":"42","author":"C Berckelaer Van","year":"2016","unstructured":"Van Berckelaer C, Brouwers AJ, Peeters DJ et al (2016) Current and future role of circulating tumor cells in patients with epithelial ovarian cancer. Eur J Surg Oncol 42:1772\u20131779","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"1_CR147","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm.3391","volume":"19","author":"L Wan","year":"2013","unstructured":"Wan L, Pantel K, Kang Y (2013) Tumor metastasis: moving new biological insights into the clinic. Nat Med 19(11):1450\u20131464","journal-title":"Nat Med"},{"issue":"16","key":"1_CR148","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1158\/1078-0432.CCR-04-0245","volume":"10","author":"G Wiedswang","year":"2004","unstructured":"Wiedswang G, Borgen E, Karesen R et al (2004) Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res 10(16):5342\u20135348","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1_CR149","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/1078-0432.CCR-08-1515","volume":"15","author":"SC Wong","year":"2009","unstructured":"Wong SC, Chan CM, Ma BB et al (2009) Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res 15(3):1005\u20131012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1_CR150","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1593\/tlo.13535","volume":"6","author":"Y Yu","year":"2013","unstructured":"Yu Y, Chen Z, Dong J et al (2013) Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer. Transl Oncol 6(6):697\u2013702","journal-title":"Transl Oncol"},{"issue":"6193","key":"1_CR151","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.1253533","volume":"345","author":"M Yu","year":"2014","unstructured":"Yu M, Bardia A, Aceto N et al (2014) Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345(6193):216\u2013220","journal-title":"Science"}],"container-title":["Advances in Experimental Medicine and Biology","Isolation and Molecular Characterization of Circulating Tumor Cells"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-55947-6_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:13:25Z","timestamp":1750281205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-55947-6_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319559469","9783319559476"],"references-count":151,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-55947-6_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2017]]}}}